NCT02710617View on ClinicalTrials.gov

System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Diabetes
Interventions
DEVICE

Blood glucose monitoring systems for point-of-care-testing

Trial Locations (1)

89081

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm

All Listed Sponsors
lead

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

OTHER

NCT02710617 - System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System | Biotech Hunter | Biotech Hunter